Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France | Zendy

Ruth Gilbert | Zendy; Luuk Gras | Zendy; Martine Wallon | Zendy; François Peyron | Zendy; A. E. Ades | Zendy; David Dunn | Zendy

Open Access

Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France

Author(s) -

Ruth Gilbert,

Luuk Gras,

Martine Wallon,

François Peyron,

A. E. Ades,

David Dunn

Publication year - 2001

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/30.6.1303

Subject(s) - medicine , seroconversion , pregnancy , transmission (telecommunications) , pediatrics , obstetrics , cohort , spiramycin , toxoplasma gondii , prenatal care , toxoplasmosis , gestation , cohort study , serology , immunology , population , biology , human immunodeficiency virus (hiv) , antibody , antibiotics , genetics , erythromycin , microbiology and biotechnology , environmental health , electrical engineering , engineering

The aim of prenatal serological screening for toxoplasmosis is to identify and treat maternal infection as soon as possible in order to prevent transmission of the parasite to the fetus. However, despite widespread provision of prenatal toxoplasma screening across Europe, the effectiveness of prenatal treatment is uncertain. The study aimed to determine the effect of the timing and type of prenatal treatment on mother to child transmission of Toxoplasma gondii.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research